Are you up-to-date on diabetes medications?
Learn how the newest weapons in the arsenal of antihyperglycemic drugs can help your patient manage her disease.
Scemons
Donna
D
D000682:Amyloid / Q000627:therapeutic use; D001549:Benzamides / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D016903:Drug Monitoring; D000077270:Exenatide; D006442:Glycated Hemoglobin / Q000378:metabolism; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D058228:Islet Amyloid Polypeptide; D018579:Patient Selection; D010455:Peptides / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use
D000682:Amyloid; D001549:Benzamides; D001645:Biguanides; D001786:Blood Glucose; D000077270:Exenatide; D006442:Glycated Hemoglobin; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D010455:Peptides; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D014688:Venoms; C030516:meglitinide; C105254:pramlintide